Rs 58 Crore Revenue! Enhertu Leads India's New Drug Sales in 2024, Reflecting Rising Cancer Cases
AstraZeneca’s Enhertu (trastuzumab deruxtecan) emerged as the highest-selling new drug in India in 2024, generating Rs 58 ...
Daily10h
Aurobindo Pharma arm gets marketing authorisation for Zefylti in EU
Hyderabad: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the ...
Daily8d
IPCA Labs to Launch Maharashtra's First Fully Green Pharma Plant in Wardha
IPCA Laboratories, a prominent pharmaceutical company, is set to inaugurate its first manufacturing unit in Vidarbha, ...
India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand ...